Literature DB >> 25433652

Comparison of pharmacy-based measures of adherence to antiretroviral therapy as predictors of virological failure.

Cassidy E Henegar1, Daniel Westreich, Mhairi Maskew, M Alan Brookhart, William C Miller, Pappie Majuba, Annelies Van Rie.   

Abstract

We compared multiple pharmacy refill-based adherence indicators for antiretroviral therapy, as well as thresholds for defining non-adherent behavior, based on ability to predict virological failure. A total of 29,937 pharmacy visits with corresponding viral load assessments were contributed by 8,695 patients attending a large clinic in Johannesburg, South Africa. Indicators based on pill coverage and timing of refill pickup performed comparably using the strictest thresholds for adherence [100 % pill coverage: odds ratio (OR) (95 % confidence interval (CI)) : 1.26 (1.15, 1.39); prescription picked up on or before scheduled refill date: 1.27 (1.16,1.38)]. For both types of indicators, the association between non-adherence and virological failure increased as the threshold defining adherent behavior was lowered. All measures demonstrated high specificity (range 84-98 %), but low sensitivity (5-19 %). In this setting, patients identified as non-adherent using pharmacy-based indicators are likely correctly classified and in need of interventions to improve compliance. Pharmacy based measures alone, however, are inadequate for identifying most cases of nonadherence.

Entities:  

Mesh:

Year:  2015        PMID: 25433652      PMCID: PMC4393758          DOI: 10.1007/s10461-014-0953-2

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  21 in total

Review 1.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors:  Margaret Sullivan Pepe; Holly Janes; Gary Longton; Wendy Leisenring; Polly Newcomb
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

2.  A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.

Authors:  Robert Grossberg; Yawei Zhang; Robert Gross
Journal:  J Clin Epidemiol       Date:  2004-10       Impact factor: 6.437

3.  Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.

Authors:  Lisa M Hess; Marsha A Raebel; Douglas A Conner; Daniel C Malone
Journal:  Ann Pharmacother       Date:  2006 Jul-Aug       Impact factor: 3.154

4.  The elusive gold standard. Future perspectives for HIV adherence assessment and intervention.

Authors:  Margaret A Chesney
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

Review 5.  Use of pharmacy refill data as a measure of antiretroviral adherence.

Authors:  Robert Grossberg; Robert Gross
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

Review 6.  Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Authors:  Edward J Mills; Jean B Nachega; Iain Buchan; James Orbinski; Amir Attaran; Sonal Singh; Beth Rachlis; Ping Wu; Curtis Cooper; Lehana Thabane; Kumanan Wilson; Gordon H Guyatt; David R Bangsberg
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

7.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

8.  Antiretroviral-drug resistance among patients recently infected with HIV.

Authors:  Susan J Little; Sarah Holte; Jean-Pierre Routy; Eric S Daar; Marty Markowitz; Ann C Collier; Richard A Koup; John W Mellors; Elizabeth Connick; Brian Conway; Michael Kilby; Lei Wang; Jeannette M Whitcomb; Nicholas S Hellmann; Douglas D Richman
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 9.  Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.

Authors:  David R Bangsberg
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

10.  Class-sparing regimens for initial treatment of HIV-1 infection.

Authors:  Sharon A Riddler; Richard Haubrich; A Gregory DiRienzo; Lynne Peeples; William G Powderly; Karin L Klingman; Kevin W Garren; Tania George; James F Rooney; Barbara Brizz; Umesh G Lalloo; Robert L Murphy; Susan Swindells; Diane Havlir; John W Mellors
Journal:  N Engl J Med       Date:  2008-05-15       Impact factor: 91.245

View more
  6 in total

1.  Barriers and facilitators of antiretroviral therapy adherence in rural Eastern province, Zambia: the role of household economic status.

Authors:  Rainier Masa; Gina Chowa; Victor Nyirenda
Journal:  Afr J AIDS Res       Date:  2017-06-22       Impact factor: 1.300

2.  Walking and perceived lack of safety: Correlates and association with health outcomes for people living with HIV in rural Zambia.

Authors:  Rainier Masa; Stefani Baca-Atlas; Peter Hangoma
Journal:  J Transp Health       Date:  2021-07-20

3.  The Association of Material Hardship with Medication Adherence and Perceived Stress Among People Living with HIV in Rural Zambia.

Authors:  Rainier Masa; Gina Chowa
Journal:  Glob Soc Welf       Date:  2018-09-05

4.  Factors affecting optimal adherence to antiretroviral therapy and viral suppression amongst HIV-infected prisoners in South Ethiopia: a comparative cross-sectional study.

Authors:  Terefe Gone Fuge; George Tsourtos; Emma R Miller
Journal:  AIDS Res Ther       Date:  2022-01-29       Impact factor: 2.250

5.  Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.

Authors:  Mhairi Maskew; Lise Jamieson; Given Mohomi; Lawrence Long; Constance Mongwenyana; Cynthia Nyoni; Dorah Mokaba; Matthew P Fox; Ian Sanne; Sydney Rosen
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

6.  Comparative Analysis of two Methods of Measuring Antiretroviral Therapy Adherence in HIV-Infected Omani Patients.

Authors:  Zied Gaifer; Mohamed-Rachid Boulassel
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.